Why the study?
Does convalescent serum therapy reduce mortality and paralysis in patients with acute poliomyelitis?
Does convalescent serum therapy reduce mortality and paralysis in patients with acute poliomyelitis?
Early literature suggests convalescent serum therapy may reduce mortality and paralysis in acute poliomyelitis.
Answers are grounded in this paper and cite their sources.
May support convalescent serum in preparalytic polio; hypothesis-generating from Level 5 data, controlled trials needed.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Paul H. Harmon (1934) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: